cDNA accession Links to the sequence |
Tissue most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features | Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
AA360708 | .i-u | 1 to 384 | 1 to 385 | tiling clone, | 385/385 (100 %) | 4 diff (99.0 %id) | |||
AV702961 | adrenal gland | .l | 47 to 645 | 1 to 598 | F46L | tiling clone, AAA | 598/598 (100 %) | 15 diff (97.5 %id) | |
AK001066 | whole embryo, mainly head | .c | 1 to 1347 | 2 to 1348 | exact | tiling clone, available from FLJ, | 1348/1348 (100 %) | 0 diff (100 %id) | |
AK225643 | Spleen | .c | 49 to 1347 | 1 to 1299 | I32V N93S F116I R134C | tiling clone, AAA | 1299/1299 (100 %) | 8 diff (99.4 %id) | |
AK293492 | cerebellum | .a | 80 to 1491 | 1 to 1412 | tiling clone, | 1412/1412 (100 %) | 1 diff (100.0 %id) | ||
AW836395 | leiomios | .l | 1 to 270 | 301 to 33 | tiling clone, | 269/314 (85 %) | 0 diff (100 %id) | ||
AW882844 | ovary | .a | 850 to 1199 | 351 to 2 | 350/351 (99 %) | 0 diff (100 %id) | |||
BG943839 | blood | .b | 41 to 341 | 1 to 301 | 301/301 (100 %) | 1 diff (99.7 %id) | |||
BC008781 | Uterus, endometrium adenocarcinoma | .c | 82 to 1347 | 1 to 1266 | I32V N93S F116I R134C | available from MGC, AAA | 1266/1266 (100 %) | 8 diff (99.4 %id) | |
BF089396 | head_neck | .c | 65 to 361 | 17 to 310 | 294/310 (94 %) | 6 diff (98.1 %id) | |||
BF089403 | head_neck | .d | 33 to 272 | 242 to 1 | 245/242 (101 %) | 14 diff (94.3 %id) | |||
BM272652 | insulinoma, Pancreas | .a | 830 to 1271 | 468 to 27 | AAA | 442/442 (100 %) | 2 diff (99.6 %id) | ||
BM272891 | insulinoma, Pancreas | .c | 81 to 622 | 8 to 549 | 542/549 (98 %) | 4 diff (99.3 %id) | |||
BQ304234 | breast | .b | 618 to 774 | 1 to 156 | 156/164 (95 %) | 6 diff (96.4 %id) | |||
BQ353522 | head_neck | .k | 146 to 324 | 177 to 355 | N41K | tiling clone, | 342/355 (96 %) | 1 diff (99.8 %id) | |
DC302781 | cerebellum | .b | 73 to 628 | 1 to 556 | 556/556 (100 %) | 0 diff (100 %id) | |||
BX119233 | senescent fibroblast | .a | 308 to 965 | 1 to 658 | 658/658 (100 %) | 0 diff (100 %id) | |||
BX283091 | astrocytoma grade IV, cell line, brain | .j | 29 to 545 | 1 to 517 | I32V | 517/517 (100 %) | 3 diff (99.5 %id) | ||
BP204186 | coronary artery | .c | 66 to 647 | 1 to 582 | 582/582 (100 %) | 4 diff (99.4 %id) | |||
CD385081 | embryonic trophoblasts, made from WA01 stemcells | .a | 1 to 817 | 18 to 843 | F216V G217W S218Q K219* | tiling clone, | 826/884 (93 %) | 23 diff (97.4 %id) | |
CD390188 | embryonic trophoblasts, made from WA01 stemcells | .a | 13 to 811 | 17 to 826 | 810/948 (85 %) | 21 diff (97.8 %id) | |||
CD696061 | normal nasopharynx | .f | 1 to 372 | 18 to 388 | 371/388 (95 %) | 2 diff (99.5 %id) | |||
CN365198 | embryonic stem cells, cell lines H1, H7, andH9 | .c | 92 to 786 | 12 to 707 | exact | 696/707 (98 %) | 1 diff (99.9 %id) | ||
CN365199 | embryonic stem cells, DMSO-treated H9 cellline | .f | 20 to 750 | 1 to 731 | F132V | tiling clone, | 731/731 (100 %) | 6 diff (99.2 %id) | |
CR600640 | Placenta Cot 25-normalized | .m | 1 to 880 | 1 to 880 | exact | tiling clone, | 880/880 (100 %) | 0 diff (100 %id) | |
AL528913 | brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized | .b | 954 to 1796 | 846 to 1 | tiling clone, | 846/846 (100 %) | 13 diff (98.5 %id) | ||
AL528914 | brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized | .b | 1 to 786 | 1 to 786 | A2D I45V N106S F129I R147C | tiling clone, | 786/786 (100 %) | 6 diff (99.3 %id) | |
AL538334 | brain, fetal brain | .e | 1 to 853 | 1 to 853 | exact | tiling clone, | 853/853 (100 %) | 0 diff (100 %id) | |
AL567260 | brain, fetal brain | .e | 949 to 1866 | 917 to 1 | tiling clone, | 917/917 (100 %) | 4 diff (99.6 %id) | ||
BX348831. matches multiple genes | Placenta Cot 25-normalized | .a | 1134 to 1272 | 1 to 141 | also hits gene P2RX5andTAX1BP3 | 141/145 (97 %) | 5 diff (96.6 %id) | ||
BX348837 | Placenta Cot 25-normalized | .a | 1137 to 1272 | 1 to 137 | 137/142 (96 %) | 4 diff (97.2 %id) | |||
BX397430 | Placenta Cot 25-normalized | .m | 1 to 851 | 851 to 1 | D3B | 851/851 (100 %) | 10 diff (98.9 %id) | ||
BX397431 | Placenta Cot 25-normalized | .m | 1 to 880 | 1 to 880 | exact | 880/880 (100 %) | 5 diff (99.5 %id) | ||
DT217462 | brain | .b | 40 to 722 | 1 to 683 | tiling clone, | 683/683 (100 %) | 1 diff (99.9 %id) | ||
DT217635 | brain | .b | 40 to 725 | 1 to 687 | 687/691 (99 %) | 3 diff (99.6 %id) | |||
DW435363 | Liver | .a | 642 to 880 | 17 to 255 | 239/255 (93 %) | 0 diff (100 %id) | |||
FN058327 | breast carcinoma | .b | 627 to 714 | 87 to 1 | Submitted on the opposite strand | 87/88 (98 %) | 2 diff (97.8 %id) | ||
FN130656 | breast carcinoma | .a | 681 to 771 | 90 to 1 | Submitted on the opposite strand | 90/91 (98 %) | 3 diff (96.8 %id) | ||
FN165508 | breast carcinoma | .b | 646 to 747 | 1 to 104 | 104/104 (100 %) | 3 diff (97.2 %id) | |||
AU119047 | whole embryo, mainly head | .c | 1 to 807 | 2 to 808 | exact | fully sequenced, capped | 807/807 (100 %) | 0 diff (100 %id) | |
AU145477 | whole embryo, mainly head | .c | 777 to 1347 | 566 to 1 | fully sequenced, | 566/566 (100 %) | 13 diff (97.8 %id) | ||
AV721108 | hypothalamus | .a | 411 to 819 | 1 to 409 | 409/418 (97 %) | 4 diff (99.1 %id) | |||
T97305 | liver and spleen | .a | 1162 to 1275 | 119 to 6 | 114/119 (95 %) | 0 diff (100 %id) | |||
H30210 | eye, retina | .a | 451 to 882 | 1 to 437 | 437/443 (98 %) | 10 diff (97.8 %id) | |||
H30211 | eye, retina | .a | 998 to 1260 | 276 to 14 | 263/281 (93 %) | 0 diff (100 %id) | |||
N59111 | liver and spleen | .a | 887 to 1271 | 385 to 1 | 385/385 (100 %) | 4 diff (99.0 %id) | |||
W46625 | senescent fibroblast | .a | 886 to 1271 | 385 to 1 | 385/386 (99 %) | 2 diff (99.5 %id) | |||
W46659 | senescent fibroblast | .a | 306 to 738 | 1 to 436 | 436/436 (100 %) | 4 diff (99.1 %id) | |||
AA702678 | liver and spleen | .a | 850 to 1271 | 421 to 1 | 421/421 (100 %) | 6 diff (98.6 %id) | |||
AA193249 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 788 to 1218 | 1 to 432 | 432/435 (99 %) | 13 diff (97.1 %id) | |||
AA253324 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 492 to 928 | 1 to 437 | 437/439 (99 %) | 2 diff (99.6 %id) | |||
AA262348 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 1042 to 1271 | 230 to 1 | 230/230 (100 %) | 3 diff (98.7 %id) | |||
AA259040 | germinal center B cell | .a | 444 to 857 | 1 to 414 | 414/414 (100 %) | 2 diff (99.6 %id) | |||
AA258182. matches multiple genes | germinal center B cell | .a | 829 to 1272 | 446 to 4 | also hits gene ARHGEF12 | 443/446 (99 %) | 0 diff (100 %id) | ||
AA469093 | colon | .a | 1040 to 1272 | 236 to 4 | 233/236 (98 %) | 0 diff (100 %id) | |||
AA737344 | Ewing's sarcoma | .a | 304 to 796 | 1 to 493 | 493/493 (100 %) | 2 diff (99.6 %id) | |||
AA740923 | germinal center B cell | .a | 922 to 1208 | 286 to 1 | 286/286 (100 %) | 3 diff (99.0 %id) | |||
AI038038 | .a | 892 to 1272 | 386 to 6 | 381/386 (98 %) | 0 diff (100 %id) | ||||
AI167272 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 834 to 1271 | 437 to 1 | 437/437 (100 %) | 2 diff (99.6 %id) | |||
AI057379 | liver and spleen | .a | 1053 to 1271 | 236 to 18 | AAA | 219/219 (100 %) | 0 diff (100 %id) | ||
AI093302 | uterus | .a | 862 to 1271 | 429 to 20 | AAA | 410/410 (100 %) | 0 diff (100 %id) | ||
AI126350 | uterus | .a | 830 to 1271 | 453 to 14 | AAA | 440/440 (100 %) | 1 diff (99.8 %id) | ||
AI271660 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 831 to 1271 | 441 to 1 | 441/441 (100 %) | 0 diff (100 %id) | |||
AI197936 | Prostate | .a | 873 to 1271 | 399 to 1 | 399/399 (100 %) | 2 diff (99.5 %id) | |||
AI335775 | uterus | .a | 865 to 1272 | 416 to 9 | 408/416 (98 %) | 0 diff (100 %id) | |||
AI379901 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 829 to 1264 | 441 to 1 | 441/441 (100 %) | 7 diff (98.5 %id) | |||
AI420249 | Prostate | .a | 651 to 1113 | 465 to 3 | 463/465 (99 %) | 0 diff (100 %id) | |||
AI422883 | brain, glioblastoma (pooled) | .a | 742 to 1271 | 530 to 1 | 530/530 (100 %) | 0 diff (100 %id) | |||
AI424620 | brain, glioblastoma (pooled) | .a | 1030 to 1272 | 243 to 1 | 243/248 (97 %) | 0 diff (100 %id) | |||
AI399793 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 844 to 1271 | 428 to 1 | 428/428 (100 %) | 0 diff (100 %id) | |||
AI400386 | Prostate | .a | 897 to 1272 | 376 to 1 | 376/376 (100 %) | 0 diff (100 %id) | |||
AI800216 | Kidney | .a | 932 to 1271 | 355 to 16 | AAA | 340/340 (100 %) | 2 diff (99.5 %id) | ||
AI638448 | pooled germ cell tumors | .a | 1043 to 1271 | 263 to 35 | AAA | 229/229 (100 %) | 3 diff (98.7 %id) | ||
AI633938 | pooled germ cell tumors | .a | 885 to 1271 | 399 to 13 | AAA | 387/387 (100 %) | 2 diff (99.5 %id) | ||
AI918945 | Prostate | .a | 758 to 1113 | 357 to 2 | 356/357 (99 %) | 0 diff (100 %id) | |||
AI768684 | Kidney | .a | 763 to 1271 | 509 to 1 | 509/509 (100 %) | 5 diff (99.1 %id) | |||
AI761154 | colon, colon tumor, RER+ | .a | 268 to 891 | 625 to 1 | 625/625 (100 %) | 23 diff (96.4 %id) | |||
AI871929 | moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus | .a | 742 to 1054 | 313 to 1 | 313/313 (100 %) | 0 diff (100 %id) | |||
AI961107 | pooled germ cell tumors | .a | 781 to 1272 | 497 to 6 | 492/497 (98 %) | 0 diff (100 %id) | |||
BI491162 | cochlea, ear | .a | 734 to 1271 | 565 to 29 | AAA | 537/539 (99 %) | 6 diff (98.9 %id) | ||
AW020130 | cochlea, ear | .a | 732 to 1193 | 1 to 461 | 461/461 (100 %) | 7 diff (98.5 %id) | |||
AI964032 | pooled germ cell tumors | .a | 906 to 1272 | 372 to 6 | 367/372 (98 %) | 0 diff (100 %id) | |||
AI968774 | pooled germ cell tumors | .a | 955 to 1272 | 325 to 8 | 318/325 (97 %) | 0 diff (100 %id) | |||
AI982940 | pooled germ cell tumors | .a | 834 to 1272 | 446 to 8 | 439/446 (98 %) | 0 diff (100 %id) | |||
AW237254 | pooled germ cell tumors | .a | 799 to 1272 | 479 to 6 | 474/479 (98 %) | 0 diff (100 %id) | |||
AW014177 | .a | 819 to 1271 | 470 to 18 | AAA | 453/453 (100 %) | 4 diff (99.2 %id) | |||
AW297750 | .a | 988 to 1151 | 3 to 166 | Submitted on the opposite strand | 164/176 (93 %) | 0 diff (100 %id) | |||
AW418503 | 2 pooled tumors (clear cell type), Kidney | .a | 1019 to 1272 | 256 to 3 | 254/257 (98 %) | 0 diff (100 %id) | |||
AW589933 | pooled germ cell tumors | .a | 828 to 1272 | 450 to 6 | 445/450 (98 %) | 0 diff (100 %id) | |||
BE463910 | pooled germ cell tumors | .a | 828 to 1271 | 456 to 13 | AAA | 444/444 (100 %) | 5 diff (98.9 %id) | ||
BE673522 | Prostate | .a | 879 to 1272 | 394 to 1 | 394/394 (100 %) | 0 diff (100 %id) | |||
BF589478 | Prostate | .a | 873 to 1272 | 405 to 6 | 400/405 (98 %) | 0 diff (100 %id) | |||
BF432345 | brain, glioblastoma (pooled) | .a | 1058 to 1255 | 200 to 1 | 200/200 (100 %) | 2 diff (99.0 %id) | |||
CB051442 | Prostate | .a | 1040 to 1261 | 222 to 1 | fully sequenced, | 222/222 (100 %) | 2 diff (99.1 %id) | ||
CB051443 | Prostate | .a | 841 to 1070 | 5 to 234 | fully sequenced, | 230/234 (98 %) | 5 diff (97.9 %id) | ||
BE257750 | eye, retinoblastoma | .a | 178 to 834 | 1 to 651 | 651/659 (98 %) | 14 diff (97.9 %id) | |||
BF056992 | pooled germ cell tumors | .a | 715 to 1272 | 563 to 6 | 558/563 (99 %) | 0 diff (100 %id) | |||
BE267259 | lung, small cell carcinoma | .a | 125 to 927 | 10 to 802 | 793/859 (92 %) | 23 diff (97.4 %id) | |||
BF196564 | brain, glioblastoma (pooled) | .a | 746 to 1271 | 526 to 1 | 526/526 (100 %) | 1 diff (99.9 %id) | |||
BE378164 | endometrium, adenocarcinoma cell line, uterus | .c | 101 to 608 | 1 to 508 | 508/508 (100 %) | 4 diff (99.3 %id) | |||
BE408905 | choriocarcinoma, placenta | .f | 52 to 588 | 1 to 539 | 537/543 (98 %) | 7 diff (98.8 %id) | |||
BF437211 | Prostate | .a | 1016 to 1272 | 257 to 1 | 257/257 (100 %) | 0 diff (100 %id) | |||
BE868016 | adenocarcinoma, colon | .c | 97 to 652 | 1 to 553 | 553/553 (100 %) | 6 diff (99.0 %id) | |||
BE889754 | leiomyosarcoma, uterus | .d | 1 to 636 | 1 to 638 | P161R P162H Y163I C165A I166L ... | tiling clone, | 638/875 (72 %) | 8 diff (99.1 %id) | |
BF125284 | melanotic melanoma, skin | .f | 54 to 719 | 1 to 651 | 651/866 (75 %) | 26 diff (97.0 %id) | |||
BF127512 | leiomyosarcoma cell line, uterus | .c | 91 to 787 | 1 to 698 | P162H Y163I C165A I166L E167R ... | 698/698 (100 %) | 9 diff (98.8 %id) | ||
BF215141 | bone marrow, from acute myelogenous leukemia | .b | 41 to 665 | 1 to 626 | 626/627 (99 %) | 28 diff (95.6 %id) | |||
BF685392 | leiomyosarcoma cell line, uterus | .c | 71 to 823 | 1 to 747 | L84C L85F H86M V87F S88Q ... | 747/923 (80 %) | 42 diff (95.5 %id) | ||
BF684844 | leiomyosarcoma cell line, uterus | .c | 71 to 826 | 1 to 754 | E48K E49N C50V Y51M A52L ... | 754/935 (80 %) | 18 diff (98.1 %id) | ||
BF684845 | leiomyosarcoma cell line, uterus | .c | 71 to 761 | 1 to 688 | V190S Y191T T192H L193Y S194P ... | 688/691 (99 %) | 5 diff (99.3 %id) | ||
BF973681 | leiomyosarcoma cell line, uterus | .c | 71 to 784 | 1 to 715 | K184R V185* | 715/1146 (62 %) | 18 diff (98.5 %id) | ||
BG034693 | breast, mammary adenocarcinoma, cell line | .a | 493 to 1249 | 1 to 752 | 752/805 (93 %) | 15 diff (98.2 %id) | |||
BG104586 | adrenal cortex carcinoma, cell line, adrenal gland | .a | 853 to 1271 | 1 to 420 | AAA | 420/420 (100 %) | 1 diff (99.8 %id) | ||
BG330258 | large cell carcinoma, lung | .f | 51 to 803 | 1 to 735 | V15F L16A L17S H18C V19F ... | tiling clone, | 735/937 (78 %) | 31 diff (96.7 %id) | |
BG337375 | leiomyosarcoma cell line, uterus | .c | 71 to 783 | 1 to 711 | exact | 711/715 (99 %) | 4 diff (99.5 %id) | ||
BG472683 | eye, retinoblastoma | .c | 76 to 701 | 1 to 627 | 627/643 (97 %) | 8 diff (98.8 %id) | |||
BG528966 | adenocarcinoma, Prostate | .f | 6 to 657 | 1 to 652 | tiling clone, | 652/652 (100 %) | 6 diff (99.1 %id) | ||
BG741206 | skin | .c | 112 to 928 | 1 to 811 | S15A P17R R18G D19T A20P ... | 811/900 (90 %) | 18 diff (98.0 %id) | ||
BG745104 | blood, natural killer cells, cell line | .a | 316 to 1223 | 912 to 2 | 911/1015 (89 %) | 13 diff (98.8 %id) | |||
BI085626 | astrocytoma grade IV, cell line, brain | .j | 29 to 717 | 1 to 691 | I32V | tiling clone, fully sequenced, | 691/691 (100 %) | 6 diff (99.2 %id) | |
BI086105 | astrocytoma grade IV, cell line, brain | .j | 685 to 1324 | 644 to 1 | tiling clone, fully sequenced, | 644/644 (100 %) | 10 diff (98.5 %id) | ||
BI755641 | brain | .c | 65 to 803 | 1 to 743 | F142L F196L T197H H198I R199G ... | 743/885 (83 %) | 14 diff (98.5 %id) | ||
BI758635 | brain | .c | 66 to 624 | 23 to 595 | 573/958 (59 %) | 21 diff (97.9 %id) | |||
BI916514 | brain | .c | 62 to 752 | 1 to 691 | exact | 691/691 (100 %) | 0 diff (100 %id) | ||
BM017624 | astrocytoma grade IV, cell line, brain | .j | 29 to 846 | 1 to 824 | I32V | tiling clone, | 824/824 (100 %) | 17 diff (98.0 %id) | |
BM552142 | astrocytoma grade IV, cell line, brain | .j | 30 to 893 | 1 to 872 | I32V | tiling clone, | 872/1023 (85 %) | 15 diff (98.6 %id) | |
BM468411 | melanotic melanoma, skin | .a | 37 to 948 | 1 to 923 | AAA | 923/923 (100 %) | 12 diff (98.7 %id) | ||
CK905082 | insulinoma, Pancreas | .c | 939 to 1284 | 346 to 1 | 346/346 (100 %) | 5 diff (98.6 %id) | |||
CK905083 | insulinoma, Pancreas | .c | 81 to 562 | 8 to 489 | 482/489 (98 %) | 8 diff (98.4 %id) | |||
BQ421845 | large cell carcinoma, lung | .a | 377 to 1271 | 12 to 906 | AAA | 895/906 (98 %) | 8 diff (99.2 %id) | ||
BU599156 | mixed (pool of 40 RNAs) | .a | 301 to 1049 | 10 to 768 | 759/855 (88 %) | 22 diff (97.5 %id) | |||
BU556535 | ovary, teratocarcinoma, cell line | .c | 83 to 959 | 1 to 888 | P105S C106L L107P F108L D109* | 888/969 (91 %) | 16 diff (98.4 %id) | ||
BU941675 | mixed (pool of 40 RNAs) | .a | 240 to 948 | 1 to 712 | 712/796 (89 %) | 16 diff (98.0 %id) | |||
BU942981 | mixed (pool of 40 RNAs) | .a | 431 to 1197 | 1 to 778 | 778/790 (98 %) | 32 diff (96.0 %id) | |||
TI_57218599 | .c | 66 to 624 | 23 to 595 | 573/958 (59 %) | 21 diff (97.9 %id) | ||||
TI_57218674 | .c | 57 to 803 | 28 to 778 | F142L F196L T197H H198I R199G ... | 751/920 (81 %) | 14 diff (98.5 %id) | |||
TI_57239975 | .c | 62 to 752 | 33 to 723 | exact | 691/723 (95 %) | 0 diff (100 %id) | |||
TI_59388129 | .j | 29 to 846 | 61 to 884 | I32V | 824/824 (100 %) | 17 diff (98.0 %id) | |||
CB114704 | Liver | .j | 233 to 831 | 1 to 599 | tiling clone, | 599/599 (100 %) | 4 diff (99.4 %id) | ||
CB157235 | Liver | .j | 1 to 556 | 1 to 556 | I32V | tiling clone, | 556/556 (100 %) | 3 diff (99.5 %id) | |
CB161316 | Liver | .a | 663 to 1126 | 1 to 464 | 464/464 (100 %) | 0 diff (100 %id) | |||
NM_018024.1 | .c | 1 to 1347 | 2 to 1348 | exact | RefSeq, | 1348/1348 (100 %) | 0 diff (100 %id) | ||
CB104761 | Ascites, stomach | .i-u | 47 to 514 | 1 to 468 | 468/468 (100 %) | 1 diff (99.8 %id) | |||
CB104828 | Ascites, stomach | .i-u | 47 to 737 | 1 to 692 | F48X C50L L51F N52E S53Q ... | tiling clone, | 692/692 (100 %) | 2 diff (99.8 %id) | |
TI_1948144962 | .d | 32 to 497 | 123 to 588 | 466/493 (94 %) | 4 diff (99.2 %id) | ||||
TI_1948145169 | .c | 124 to 740 | 125 to 744 | 618/1363 (45 %) | 15 diff (98.9 %id) | ||||
BP338733 | Spleen | .c | 81 to 661 | 1 to 581 | 581/581 (100 %) | 4 diff (99.4 %id) | |||
BP339344 | Spleen | .c | 49 to 631 | 1 to 583 | 583/583 (100 %) | 4 diff (99.4 %id) | |||
BP348037 | brain | .b | 15 to 596 | 1 to 583 | 583/583 (100 %) | 2 diff (99.7 %id) | |||
DN992564 | brain, whole brain | .c | 82 to 671 | 9 to 598 | 590/598 (98 %) | 4 diff (99.4 %id) | |||
BE241599 | leukopheresis | .h | 1 to 322 | 1 to 322 | tiling clone, | 322/322 (100 %) | 3 diff (99.1 %id) | ||
BM194112 | leukopheresis | .h | 1 to 499 | 1 to 498 | V37S E38* | tiling clone, | 498/498 (100 %) | 7 diff (98.6 %id) | |
DB147766 | thymus | .g-u | 1 to 582 | 2 to 584 | R29X A30G Q31A P32A L33S ... | tiling clone, capped | 583/583 (100 %) | 1 diff (99.9 %id) | |
CA313379 | Human Lung Epithelial cells, lung | .a | 576 to 1271 | 713 to 19 | AAA | 695/700 (99 %) | 4 diff (99.5 %id) | ||
BQ186979 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 703 to 1272 | 1 to 570 | AAA | 570/570 (100 %) | 1 diff (99.9 %id) | ||
BU632739 | cell lines, Chondrosarcoma | .a | 573 to 1271 | 715 to 19 | tiling clone, AAA | 697/697 (100 %) | 2 diff (99.8 %id) | ||
CA428619 | Cell Line, Chondrosarcoma | .a | 573 to 1271 | 714 to 19 | AAA | 696/696 (100 %) | 4 diff (99.5 %id) | ||
BU622342 | Cell Line, Chondrosarcoma | .a | 601 to 1271 | 687 to 19 | AAA | 669/669 (100 %) | 2 diff (99.8 %id) | ||
BU626637 | Alveolar Macrophage, lung | .a | 556 to 1271 | 729 to 19 | AAA | 711/724 (98 %) | 10 diff (98.7 %id) | ||
TI_151732880 | .a | 703 to 1271 | 648 to 80 | AAA | 569/971 (58 %) | 1 diff (99.9 %id) | |||
AV704765 | adrenal gland | .c | 76 to 701 | 1 to 627 | Suspected internal deletion, this clone was ignored | 627/643 (97 %) | 8 diff (98.8 %id) | ||
BG422913 | Kidney, renal cell adenocarcinoma | .f | 6 to 657 | 1 to 652 | tiling clone, | Suspected internal deletion, this clone was ignored | 652/652 (100 %) | 6 diff (99.1 %id) | |
BI085507 | astrocytoma grade IV, cell line, brain | .f | 6 to 657 | 1 to 652 | tiling clone, fully sequenced, | This clone was ignored | 652/652 (100 %) | 6 diff (99.1 %id) | |
BI085991 | astrocytoma grade IV, cell line, brain | .c | 112 to 928 | 1 to 811 | fully sequenced, | This clone was ignored | 811/900 (90 %) | 18 diff (98.0 %id) | |
BG745104 | blood, natural killer cells, cell line | .a | 316 to 1223 | 912 to 2 | 911/1015 (89 %) | 13 diff (98.8 %id) | |||
BG745104 | blood, natural killer cells, cell line | .a | 316 to 1223 | 912 to 2 | 911/1015 (89 %) | 13 diff (98.8 %id) | |||
BI085626 | astrocytoma grade IV, cell line, brain | .j | 29 to 717 | 1 to 691 | I32V | tiling clone, fully sequenced, | 691/691 (100 %) | 6 diff (99.2 %id) | |
BI085626 | astrocytoma grade IV, cell line, brain | .j | 29 to 717 | 1 to 691 | I32V | tiling clone, fully sequenced, | 691/691 (100 %) | 6 diff (99.2 %id) | |
BI086105 | astrocytoma grade IV, cell line, brain | .j | 685 to 1324 | 644 to 1 | tiling clone, fully sequenced, | 644/644 (100 %) | 10 diff (98.5 %id) | ||
BI086105 | astrocytoma grade IV, cell line, brain | .j | 685 to 1324 | 644 to 1 | tiling clone, fully sequenced, | 644/644 (100 %) | 10 diff (98.5 %id) | ||
BI755641 | brain | .c | 65 to 803 | 1 to 743 | F142L F196L T197H H198I R199G ... | 743/885 (83 %) | 14 diff (98.5 %id) | ||
BI758635 | brain | .c | 66 to 624 | 23 to 595 | 573/958 (59 %) | 21 diff (97.9 %id) | |||
BI916514 | brain | .c | 62 to 752 | 1 to 691 | exact | 691/691 (100 %) | 0 diff (100 %id) | ||
BM017624 | astrocytoma grade IV, cell line, brain | .j | 29 to 846 | 1 to 824 | I32V | tiling clone, | 824/824 (100 %) | 17 diff (98.0 %id) | |
BM017624 | astrocytoma grade IV, cell line, brain | .j | 29 to 846 | 1 to 824 | I32V | tiling clone, | 824/824 (100 %) | 17 diff (98.0 %id) | |
BM552142 | astrocytoma grade IV, cell line, brain | .j | 30 to 893 | 1 to 872 | I32V | tiling clone, | 872/1023 (85 %) | 15 diff (98.6 %id) | |
BM552142 | astrocytoma grade IV, cell line, brain | .j | 30 to 893 | 1 to 872 | I32V | tiling clone, | 872/1023 (85 %) | 15 diff (98.6 %id) | |
BM468411 | melanotic melanoma, skin | .a | 37 to 948 | 1 to 923 | AAA | 923/923 (100 %) | 12 diff (98.7 %id) | ||
BM468411 | melanotic melanoma, skin | .a | 37 to 948 | 1 to 923 | AAA | 923/923 (100 %) | 12 diff (98.7 %id) | ||
CK905082 | insulinoma, Pancreas | .c | 939 to 1284 | 346 to 1 | 346/346 (100 %) | 5 diff (98.6 %id) | |||
CK905082 | insulinoma, Pancreas | .c | 939 to 1284 | 346 to 1 | 346/346 (100 %) | 5 diff (98.6 %id) | |||
CK905083 | insulinoma, Pancreas | .c | 81 to 562 | 8 to 489 | 482/489 (98 %) | 8 diff (98.4 %id) | |||
CK905083 | insulinoma, Pancreas | .c | 81 to 562 | 8 to 489 | 482/489 (98 %) | 8 diff (98.4 %id) | |||
BQ421845 | large cell carcinoma, lung | .a | 377 to 1271 | 12 to 906 | AAA | 895/906 (98 %) | 8 diff (99.2 %id) | ||
BQ421845 | large cell carcinoma, lung | .a | 377 to 1271 | 12 to 906 | AAA | 895/906 (98 %) | 8 diff (99.2 %id) | ||
BU599156 | mixed (pool of 40 RNAs) | .a | 301 to 1049 | 10 to 768 | 759/855 (88 %) | 22 diff (97.5 %id) | |||
BU556535 | ovary, teratocarcinoma, cell line | .c | 83 to 959 | 1 to 888 | P105S C106L L107P F108L D109* | 888/969 (91 %) | 16 diff (98.4 %id) | ||
BU556535 | ovary, teratocarcinoma, cell line | .c | 83 to 959 | 1 to 888 | P105S C106L L107P F108L D109* | 888/969 (91 %) | 16 diff (98.4 %id) | ||
BU941675 | mixed (pool of 40 RNAs) | .a | 240 to 948 | 1 to 712 | 712/796 (89 %) | 16 diff (98.0 %id) | |||
BU942981 | mixed (pool of 40 RNAs) | .a | 431 to 1197 | 1 to 778 | 778/790 (98 %) | 32 diff (96.0 %id) | |||
TI_57218599 | .c | 66 to 624 | 23 to 595 | 573/958 (59 %) | 21 diff (97.9 %id) | ||||
TI_57218674 | .c | 57 to 803 | 28 to 778 | F142L F196L T197H H198I R199G ... | 751/920 (81 %) | 14 diff (98.5 %id) | |||
TI_57239975 | .c | 62 to 752 | 33 to 723 | exact | 691/723 (95 %) | 0 diff (100 %id) | |||
TI_59388129 | .j | 29 to 846 | 61 to 884 | I32V | 824/824 (100 %) | 17 diff (98.0 %id) | |||
CB114704 | Liver | .j | 233 to 831 | 1 to 599 | tiling clone, | 599/599 (100 %) | 4 diff (99.4 %id) | ||
CB157235 | Liver | .j | 1 to 556 | 1 to 556 | I32V | tiling clone, | 556/556 (100 %) | 3 diff (99.5 %id) | |
CB161316 | Liver | .a | 663 to 1126 | 1 to 464 | 464/464 (100 %) | 0 diff (100 %id) | |||
NM_018024.1 | .c | 1 to 1347 | 2 to 1348 | exact | RefSeq, | 1348/1348 (100 %) | 0 diff (100 %id) | ||
CB104761 | Ascites, stomach | .i-u | 47 to 514 | 1 to 468 | 468/468 (100 %) | 1 diff (99.8 %id) | |||
CB104761 | Ascites, stomach | .i-u | 47 to 514 | 1 to 468 | 468/468 (100 %) | 1 diff (99.8 %id) | |||
CB104828 | Ascites, stomach | .i-u | 47 to 737 | 1 to 692 | F48X C50L L51F N52E S53Q ... | tiling clone, | 692/692 (100 %) | 2 diff (99.8 %id) | |
CB104828 | Ascites, stomach | .i-u | 47 to 737 | 1 to 692 | F48X C50L L51F N52E S53Q ... | tiling clone, | 692/692 (100 %) | 2 diff (99.8 %id) | |
TI_1948144962 | .d | 32 to 497 | 123 to 588 | 466/493 (94 %) | 4 diff (99.2 %id) | ||||
TI_1948145169 | .c | 124 to 740 | 125 to 744 | 618/1363 (45 %) | 15 diff (98.9 %id) | ||||
BP338733 | Spleen | .c | 81 to 661 | 1 to 581 | 581/581 (100 %) | 4 diff (99.4 %id) | |||
BP339344 | Spleen | .c | 49 to 631 | 1 to 583 | 583/583 (100 %) | 4 diff (99.4 %id) | |||
BP348037 | brain | .b | 15 to 596 | 1 to 583 | 583/583 (100 %) | 2 diff (99.7 %id) | |||
DN992564 | brain, whole brain | .c | 82 to 671 | 9 to 598 | 590/598 (98 %) | 4 diff (99.4 %id) | |||
DN992564 | brain, whole brain | .c | 82 to 671 | 9 to 598 | 590/598 (98 %) | 4 diff (99.4 %id) | |||
BE241599 | leukopheresis | .h | 1 to 322 | 1 to 322 | tiling clone, | 322/322 (100 %) | 3 diff (99.1 %id) | ||
BM194112 | leukopheresis | .h | 1 to 499 | 1 to 498 | V37S E38* | tiling clone, | 498/498 (100 %) | 7 diff (98.6 %id) | |
DB147766 | thymus | .g-u | 1 to 582 | 2 to 584 | R29X A30G Q31A P32A L33S ... | tiling clone, capped | 583/583 (100 %) | 1 diff (99.9 %id) | |
CA313379 | Human Lung Epithelial cells, lung | .a | 576 to 1271 | 713 to 19 | AAA | 695/700 (99 %) | 4 diff (99.5 %id) | ||
CA313379 | Human Lung Epithelial cells, lung | .a | 576 to 1271 | 713 to 19 | AAA | 695/700 (99 %) | 4 diff (99.5 %id) | ||
BQ186979 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 703 to 1272 | 1 to 570 | AAA | 570/570 (100 %) | 1 diff (99.9 %id) | ||
BQ186979 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 703 to 1272 | 1 to 570 | AAA | 570/570 (100 %) | 1 diff (99.9 %id) | ||
BU632739 | cell lines, Chondrosarcoma | .a | 573 to 1271 | 715 to 19 | tiling clone, AAA | 697/697 (100 %) | 2 diff (99.8 %id) | ||
BU632739 | cell lines, Chondrosarcoma | .a | 573 to 1271 | 715 to 19 | tiling clone, AAA | 697/697 (100 %) | 2 diff (99.8 %id) | ||
CA428619 | Cell Line, Chondrosarcoma | .a | 573 to 1271 | 714 to 19 | AAA | 696/696 (100 %) | 4 diff (99.5 %id) | ||
CA428619 | Cell Line, Chondrosarcoma | .a | 573 to 1271 | 714 to 19 | AAA | 696/696 (100 %) | 4 diff (99.5 %id) | ||
BU622342 | Cell Line, Chondrosarcoma | .a | 601 to 1271 | 687 to 19 | AAA | 669/669 (100 %) | 2 diff (99.8 %id) | ||
BU622342 | Cell Line, Chondrosarcoma | .a | 601 to 1271 | 687 to 19 | AAA | 669/669 (100 %) | 2 diff (99.8 %id) | ||
BU626637 | Alveolar Macrophage, lung | .a | 556 to 1271 | 729 to 19 | AAA | 711/724 (98 %) | 10 diff (98.7 %id) | ||
BU626637 | Alveolar Macrophage, lung | .a | 556 to 1271 | 729 to 19 | AAA | 711/724 (98 %) | 10 diff (98.7 %id) | ||
TI_151732880 | .a | 703 to 1271 | 648 to 80 | AAA | 569/971 (58 %) | 1 diff (99.9 %id) |